Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.96	78.38	89.03
Graham Fair Price	-1.16	20.07	20.30
PEG	-117.22	-4.93	-2.27
Price/Book	8.22	-41.85	-45.60
Price/Cash Flow	-11.46	109.75	123.94
Prices/Earnings	-0.39	26.21	26.31
Price/Sales	-2.14	32.79	33.50
Price/FCF	-11.46	109.75	123.94
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.69	0.55	0.56
Operating Margin	-0.69	0.44	0.44
ROA	-0.74	0.04	0.04
ROE	-0.43	-0.40	7.87
ROIC	0.07	0.07	0.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	< 0.005	44.18
Dividends QOQ	0.10	< 0.005	-98.92
EBIT QOQ	-0.12	-0.04	62.66
EPS QOQ	-0.12	-0.05	54.14
FCF QOQ	-0.30	0.06	-78.25
Revenue QOQ	-0.04	-0.04	13.36
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1.67	1.50	-10.31
Days Sales Outstanding (DSO)	34.95	32.65	-6.59
Inventory Turnover	53.84	60.02	11.49
Debt/Capitalization	1.13	1.15	1.08
Quick Ratio	1.03	2.51	143.04
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-6.50	-6.70	-2.97
Cash	6.33	13.86	118.90
Capex	-1.05	-0.76	27.57
Free Cash Flow	2.39	2.55	6.73
Revenue	8.85	8.55	-3.43
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	0.83	-28.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.61	15.55	-0.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating